Next |
home / stock / ctso / ctso message board
Subject | By | Source | When |
---|---|---|---|
Plus they have a credit line facility in | Good Sport | investorshub | 07/09/2023 9:53:56 PM |
They won't run out of cash. They have | biotech48 | investorshub | 07/08/2023 9:31:48 PM |
When do they run out of cash? | ranchhand71 | investorshub | 07/07/2023 8:44:14 PM |
PR out that we've completed enrollment. | fantomphan | investorshub | 07/07/2023 12:28:30 PM |
Extracorporeal hemoadsorption therapy as a potential therapeutic option | Good Sport | investorshub | 07/07/2023 2:53:18 AM |
Cytosorbents ($CTSO) Price Target Increased by 8.57% to 7.75 | Good Sport | investorshub | 07/07/2023 2:44:05 AM |
American Journal of Case Reports | Good Sport | investorshub | 07/07/2023 2:38:49 AM |
$CTSO Lets go go go go... Up up and away we go. | fantomphan | investorshub | 07/05/2023 9:05:51 PM |
Case of the Month | andy55q | investorshub | 07/05/2023 10:38:23 AM |
Price gaining last trade up | Good Sport | investorshub | 07/05/2023 12:09:21 AM |
The now | Good Sport | investorshub | 07/04/2023 3:39:43 PM |
we got news | Good Sport | investorshub | 07/03/2023 11:22:07 AM |
$CTSO Looks pretty positive | Good Sport | investorshub | 07/02/2023 5:57:59 PM |
great article | andy55q | investorshub | 06/27/2023 8:06:14 PM |
$CTSO Time for this to show some returns | J G R | investorshub | 06/25/2023 2:46:00 PM |
$CTSO news out | fantomphan | investorshub | 06/22/2023 2:58:32 AM |
New on PubMed | andy55q | investorshub | 06/20/2023 9:43:18 AM |
$CTSO where is the squeeze? | J G R | investorshub | 06/17/2023 5:15:44 PM |
CytoSorbents Announces Independent Data Safety and Monitoring Board | Good Sport | investorshub | 06/15/2023 11:37:25 AM |
Avenir Corp Buys 132,235 Shares of Cytosorbents Co. (NASDAQ:$CTSO) | Good Sport | investorshub | 06/13/2023 8:48:27 PM |
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
Product Sales up a robust 14% over prior year, and a significant 22% sequentially We believe the STAR-T data presented at AATS support a favorable benefit-to-risk profile of DrugSorb-ATR in coronary artery bypass graft (CABG) patients On track for U.S. Food and Drug Admi...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
PRINCETON, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditio...